The Neuroprotective Effects of Cannabis-Derived Phytocannabinoids and Resveratrol in Parkinson’s Disease: A Systematic Literature Review of Pre-Clinical Studies

Currently, there are no pharmacological treatments able to reverse nigral degeneration in Parkinson’s disease (PD), hence the unmet need for the provision of neuroprotective agents. Cannabis-derived phytocannabinoids (CDCs) and resveratrol (RSV) may be useful neuroprotective agents for PD due to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Prakash, Samay, Carter, Wayne G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699487/
https://www.ncbi.nlm.nih.gov/pubmed/34942876
http://dx.doi.org/10.3390/brainsci11121573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699487/
https://www.ncbi.nlm.nih.gov/pubmed/34942876
http://dx.doi.org/10.3390/brainsci11121573

Ejemplares similares